The role of the inflammatory response in acute pancreatitis and its relation with the clinical course was examined. This study examined if the serial measurement of polymorphonuclear granulocyte (PMN) elastase/AlPI complex, phospholipase A catalytic activity, C reactive protein, and other acute phase proteins, and the protease inhibitor a2-macroglobulin, provides meaningful information for prognosis.
Abstract
The role of the inflammatory response in acute pancreatitis and its relation with the clinical course was examined. This study examined if the serial measurement of polymorphonuclear granulocyte (PMN) elastase/AlPI complex, phospholipase A catalytic activity, C reactive protein, and other acute phase proteins, and the protease inhibitor a2-macroglobulin, provides meaningful information for prognosis.
Eighty non-consecutive patients with acute pancreatitis, classified according to their clinical outcome into mild (n=40) and severe pancreatitis (n=40), were followed up daily. Between 48 hours, median values of PMN-elastase, C reactive protein -and most of the acute phase proteins -and phospholipase A activity, were significantly higher in the severe pancreatitis group. PMN elastase shows a dynamic course and it reaches an early peak value at days 1-2, followed by C reactive protein (days 2-4) phospholipase A (day 3), and a negative peak for cx2-macroglobulin (days [4] [5] . PMN elastase (day 1) and C reactive protein (day 2) were selected by discriminant analysis as the most useful variables studied to allow the early accurate prediction of severity (sensitivity 100%, specificity 95%). Little or no predictive additional value was found for all other variables studied. These results strongly suggest a close relation between inflammatory parameters and clinical course in acute pancreatitis, and discriminant analysis of these variables provides a useful method to classify severity. (Gut 1994; 35: phospholipase A catalytic activity -as marker of phagocytic activity in inflammation and necrosis16 and a2-macroglobulin, the main plasma protease inhibitor -as marker of protease/protease inhibitor imbalance. '7 Descriptive and explorative data analysis was made for all variables (days [1] [2] [3] [4] [5] . By using the data obtained within 48 hours of admission, we applied discriminant function analysis to predict severity in acute pancreatitis.
Methods

PATIENTS
We studied a group of 80 non-consecutive patients, 43 men and 37 women with a median age of 58 years (range Predictive analysis Stepwise discriminant function analysis was applied to the data obtained within 48 hours of admission to predict the severity of acute pancreatitis. Furthermore age, sex, cause of acute pancreatitis, and the increment value of all variables assayed (value at day 2 minus value at day 1) were considered. The analysis was carried out using the BMDP statistical package (BMDP P7, 1988). If x1, x2,.., xkare discriminating variables for mild and severe acute pancreatitis, the procedure establishes a linear function (discriminant function) Z=clxl +C2X2+ *--+Ckxk in which z is the score of the discriminant function for each case and c the weighing coefficient. The method used to select the discriminating variables and to determine the coefficients cl, c2,...ck develops in successive steps. With each step, a variable that is shown to have the greatest disciminating power, is included in the discriminant function. Variables that do not contribute significantly (at the 5% probability value) to the final equation are subsequently excluded from the model.
The discriminant function transforms the data on each patient into a score (z value) that can be plotted as a point on a straight line. To classify optimally a new patient as a case of severe or mild acute pancreatitis, a cut off value of z is established by considering the prevalence of severe (0 1) and mild (0 9) acute pancreatitis and the cost of erroneous classification (classification rule).
Validation
The jackknife procedure was used to validate the discriminant function. One patient at a time was removed from the sample, and the discriminant functions are recalculated for the remaining patients. The procedure was repeated for each patient in the group, and the efficacy of classification (sensitivity, specificity) was assessed. 'Jackknifed' values are a better estimate of the performance of classification in future patients than those obtained using primary discriminant analysis.
Results
SINGLE VARIABLE ANALYSIS
PMN elastase
The median peak value for PMN elastase/Al PI complex in the two groups of acute pancreatitis was reached early on days 1-2 (Fig 1) (Fig 2) . Median concentrations on days 1-5 were significantly higher (p<0 0001) in patients with severe disease than those with mild pancreatitis. Values for C reactive protein >300 mg/l were found exlusively in the group of severe pancreatitis. The median peak value of antichymotrypsin was reached on day 3. Antichymotrypsin concentration shows a time course slower than those showed by C reactive protein, on days 1-5 (Fig 3) . Median concentrations on days 1-5 were significantly higher (p<0'00001) in patients with severe disease than in those with mild pancreatitis. Within 48 hours, values for antichymotrpysin >140 mg/dl were found in 80% of patients with severe acute pancreatitis.
The concentration of a protease inhibitor increased during the pancreatic attack in both groups, but peaked earlier in patients with mild disease (at day 2) than in those with severe disease (at day 4) (Fig 4) . Median values at day 4 were significantly higher (p<0 0001) in patients with severe disease compared with those with mild pancreatitis. The cation rule, z .0: severe acute pancreatitis; z <0: mild acute pancreatitis).
catalytic activity.
We set a cut off to maximise sensitivity (that is, detection of severe cases) and specificity (optimisation of the classification oncentrations function) by considering the cost of erroneous study period, classification for severe acute pancreatitis and ase showed a the prevalence for each group (mild 0(9, severe imum on day 0-1). Therefore, the new function was: several of the z=0A46477 (SQR) (C reactive protein (day ly correlated. 2))+0-78009 (SQR) (PMN elastase (day 1)) of C reactive -15-57958 (classification rule, z .0: ichymotrypsin severe acute pancreatitis; z <0: mild acute (r=0-492), or pancreatitis).
-oncentration.
For this function, sensitivity was 100%, nt correlation specificity 95%, and the outcome was correctly of C reactive predicted in 97.2% of cases. Both variables lues on day 1 selected by the model were not correlated (r=-0 0262) and their courses are fully independent.
Phospholipase A activity The serum phospholipase A concentrations rose to high values in patients with severe disease, especially in those with necrotising pancreatitis, respiratory insufficiency, shock or sepsis. In the group of patients with severe disease, the median peak value was reached on day 3 (Fig 5) . of cellular response) and monocytes. At the site of inflammation, these cells release biologically active products, such as proteolytic enzymes, reactive oxygen metabolites, vasoactive substances, and cytokines (tumour necrosis factor a, interleukin 1, interleukin 6, interleukin 8. 13 23 24 In this study, blood concentrations of different inflammatory markers were determined to assess whether or not the intensity of inflammatory response was correlated with the severity of pancreatitis, and to obtain a reliable model for an early and accurate prediction of prognosis.
Granulocyte elastase has been shown to be a sensitive and specific marker for the early identification of inflammation, activation of granulocytes, and the predition of inflammatory complications. '4 18 In this study, granulocyte elastase was the most useful marker of severity and our results coincide with those of other authors who found higher values in patients with necrotising acute pancreatitis25 or severe disease" 2426 than in patients with mild disease. The time course of granuolocyte elastase showed an early peak on days [1] [2] showing that polymorphonuclear neutrophils become highly activated in the early stages of acute pancreatitis. This assay predicted disease severity with a sensitivity of 84%. Increased concentrations of PMN elastase were clearly associated with a poor prognosis. The PMN elastase was measured in this study by using the IMAC elastase assay (E Merck) (automated version) in plasma EDTA samples. This method correlates well with the previous sandwich enzyme linked immunosorbent assay (ELISA), and it shows satisfactory precision at the clinical decision value. The IMAC elastase performed automatically on clinical chemistry analysers, provides a fast (about 10 minutes) routine method for measurement of PMN elastase concentrations in human plasma. A negative aspect of the kit is their excessive large presentation, particularly if the elastase determination is exclusively used as an aid to clinical evaluation of acute pancreatitis. In this respect, the development by the manufacturer of several kits with different presentations is welcome. Another important concern is related to the nature of the analyte -plasma must be separated carefully from blood within 60 minutes after specimen collection to prevent interference by leakage of elastase from leucocytes.
The increased serum concentrations of C reactive protein in patients with acute pancreatitis is a consequence of activation of the monocyte-macrophage system'5 27 29 The median peak value of C reactive protein was reached later (on days 2-4) reflecting the synthesis of acute phase proteins in the liver, secondary to the release of cytokines by activated monocyte-macrophages.
Stepwise discriminant function analysis selected PMN elastase value on day 1 and C reactive protein on day 2 as the optimal combination for predicting the severity in acute pancreatitis with 100% sensitivity and 95%/ specificity. Both variables were fully independent (r= -00262) and no useful additional information was obtained from all other parameters studied. The time course of acute phase proteins, phospholipase A catalytic activity, and x2-macroglobulin was similar to that described by others.'1 17 25 27-31.
In summary, two biochemical assays easily performed routinely in most hospitals -that is, PMN elastase and C reactive protein -permit the establishment at an early stage of actual inflammatory response and predict accurately the clinical course of acute pancreatitis.
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